Trial Evaluating the Efficacy and Safety of Oral Vadadustat Once Daily (QD) and Three Times Weekly (TIW) for the Maintenance Treatment of Anemia in Hemodialysis Subjects Converting From Erythropoiesis-Stimulating Agents (ESAs)
Clinical trial NCT04313153 · COMPLETED
Trial details
- NCT number
- NCT04313153
- Sponsor
- Akebia Therapeutics
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-27
- Primary completion
- 2021-11-26
- Enrollment
- 319
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.